Life sciences are on the cutting-edge of innovation: They’re developing breakthrough drugs and vaccines, advanced medical devices and diagnostic tools, and sustainable environmental solutions. But all this advancement is exactly what makes pharmaceutical, biotech and medical device firms prime targets for cyberattacks, data breaches, fraud and even counterfeiting. And these risks are causing financial and operational disasters across the industry. That’s why comprehensive insurance programs are stepping up to offer broader, more flexible and tailored protection to ensure financial stability, regulatory compliance and investor confidence.[1]
Why life sciences are targets and how insurance is widening protection - Cyber insurance has been around for a while, but it’s evolving quickly. Here’s why life sciences are so attractive and how insurance is stepping up to meet the moment:
- IP theft: High value, high interest
In life sciences, intellectual property (IP) is the business. Proprietary drug formulas, biologics manufacturing processes, molecular models and platform technologies can be worth billions. And that kind of value doesn’t go unnoticed. For cybercriminals, biotech IP can help fast-track their own research and development. Breaches often happen through third-party research partners or cloud-based R&D platforms. Even automated lab systems, essential for innovation, can introduce unexpected entry points if unsecured.
Insurance Response - New coverage to help cover the cost of reconstructing or revaluing IP after a breach to support recovery of stolen or corrupted research assets. R&D-focused business interruption coverage to help offset losses from delayed trials and disrupted lab workflows and not just IT downtime.
- A goldmine of data
Clinical trial data, proprietary research, genomic datasets, patient records, device telemetry it’s some of the most sensitive (and valuable) data in the world. If compromised, it’s not just a privacy issue — it can derail entire product pipelines.
For cybercriminals, this kind of data can be sold, held for ransom or used to gain a competitive edge. A breach also can call into question the integrity of a clinical trial, triggering regulatory scrutiny and global compliance challenges.
Insurance Response - Expanded coverage to help with regulatory response, trial notifications and cross border privacy compliance. Clinical trial integrity protections that help cover the cost of re running compromised study arms or recollecting corrupted datasets.
- Ransoms: High pressure, high vulnerability
In most industries, downtime is inconvenient. In life sciences, it can be catastrophic.
A ransomware attack on manufacturing or lab systems can spoil cell lines, interrupt batch production and delay critical deliveries and ripple across supply chains to affect partners and customers. Unfortunately, automated labs, bioreactors and LIMS platforms often rely on legacy technology and lack modern cybersecurity. Plus, the pressure to meet strict regulatory and contractual deadlines can drive ransom payments to get systems back online as quickly as possible.
Insurance Response - Ransomware coverage is expanding to address attacks on operational technology and lab system, not just traditional IT.
Specialized coverage tailored to biologics and advanced manufacturing to help with losses tied to spoilage, sample loss and batch interruptions.
More partners, more risk
Between third-party vendors, research partners, CROs and global operations, life sciences often have sprawling digital ecosystems. More connections mean more potential entry points for attackers.
And because so many organizations are interconnected, a single breach at a vendor can end up impacting dozens of companies at once.
Insurance Response
Stronger contingent business interruption coverage that can help protect against losses tied to vendor disruptions.
Incentives for improved third-party risk management and governance practices.
Coverage extensions to better address risks tied to cloud-based lab platforms and outsourced environments.
AI: A new category of risk
Like most industries, artificial intelligence (AI) is transforming life sciences — from drug discovery to trial design. But it’s also creating new cyber exposures.
AI models can be manipulated with poisoned training data and skew results. Outputs also can be altered, or even stolen — especially when AI is used to generate valuable molecular or research-based IP.
Insurance Response
Coverage for AI model integrity issues and data poisoning to help organizations respond when systems are compromised.
Protection for the cost of retraining and rebuilding compromised models.
Insurers are now recognizing AI-generated outputs as insurable IP.
Comprehensive risk management programs
For life sciences, cyber risk isn’t just an IT issue — it’s a core business risk that touches everything from R&D to revenue. Insurance is no longer just a safety net but should be a key part of an overall risk management strategy.
Organizations that are coming out ahead treat cyber coverage as an active part of their planning, regularly review it as operations evolve, align cybersecurity controls with insurer expectations, and work with brokers and carriers who truly understand life sciences.
Innovation brings exposure, but strong internal controls and tailored insurance can mitigate these risks — because it’s likely not a question of if a cyber event will happen, but when.
This article is shared at no charge for educational and informational purposes only.
Red Sky Alliance is a Cyber Threat Analysis and Intelligence Service organization. We provide indicators of compromise information (CTI) via a notification/Tier I analysis service (RedXray) or an analysis service (CTAC). For questions, comments or assistance, please contact the office directly at 1-844-492-7225, or feedback@redskyalliance.com
Weekly Cyber Intelligence Briefings:
- Reporting: https://www.redskyalliance.org/
- Website: https://www.redskyalliance.com/
- LinkedIn: https://www.linkedin.com/company/64265941
Weekly Cyber Intelligence Briefings:
REDSHORTS - Weekly Cyber Intelligence Briefings
https://register.gotowebinar.com/register/5207428251321676122
[1] https://www.bizjournals.com/columbus/news/2026/05/01/cyber-insurance-life-sciences-threat.html
Comments